The SVP, Global Sales of Cryolife is Exercising Options


Today, the SVP, Global Sales of Cryolife, Davis John, exercised options of Cryolife for $113.7K.

In addition to Davis John, one other CRY executive reported Sell trades in the last month.

See today’s analyst top recommended stocks >>

Based on Cryolife’s latest earnings report for the quarter ending March 31, the company posted quarterly revenue of $61.95 million and GAAP net loss of $3.82 million. In comparison, last year the company earned revenue of $45.06 million and had a net profit of $2.18 million. Currently, Cryolife has an average volume of 134.4K.

Company insider trades are published daily on the SEC (Securities and Exchange Commission). DailyInsider’s proprietary algorithm analyzes these trades and selects the most attractive stocks based on influential insider trades each day. To subscribe to the DailyInsider visit this page.

TipRanks has tracked 36,000 company insiders and found that a few of them are better than others when it comes to timing their transactions. See which 3 stocks are most likely to make moves following their insider activities.

CryoLife, Inc. is a medical devices company, which engages in the processing and distribution of implantable human tissues for use in cardiac and vascular surgeries. It operates through the Medical Devices and Preservation Services segments.

Stay Ahead of Everyone Else

Get The Latest Stock News Alerts